Home/Filings/4/0001209191-18-024453
4//SEC Filing

Hora Maninder 4

Accession 0001209191-18-024453

CIK 0000906709other

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 8:22 PM ET

Size

15.4 KB

Accession

0001209191-18-024453

Insider Transaction Report

Form 4
Period: 2018-04-05
Hora Maninder
SVP Pharma Dev and Mfg
Transactions
  • Exercise/Conversion

    Common Stock

    2018-04-05$7.21/sh+20,000$144,200100,261 total
  • Exercise/Conversion

    Common Stock

    2018-04-09$7.21/sh+9,498$68,48189,759 total
  • Sale

    Common Stock

    2018-04-05$101.75/sh20,000$2,035,00080,261 total
  • Sale

    Common Stock

    2018-04-09$105.05/sh9,498$997,76580,261 total
  • Exercise/Conversion

    Stock Option

    2018-04-0520,00042,500 total
    Exercise: $7.21From: 2016-02-08Exp: 2020-02-07Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Option

    2018-04-099,49833,002 total
    Exercise: $7.21From: 2016-02-08Exp: 2020-02-07Common Stock (9,498 underlying)
Footnotes (4)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]This number includes 6,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c).
  • [F3]This transaction was executed in multiple trades at prices ranging from $100.26 - $103.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  • [F4]This transaction was executed in multiple trades at prices ranging from $105.00 - $105.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0001443159

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 8:22 PM ET
Size
15.4 KB